Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
C 22.6 -5.32% -1.27
MYOV closed down 5.32 percent on Friday, June 11, 2021, on approximately normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical MYOV trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
MACD Bearish Signal Line Cross Bearish -4.88%
1,2,3 Pullback Bullish Bullish Swing Setup -5.36%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -5.36%
Outside Day Range Expansion -5.36%
NR7 Range Contraction -4.80%
NR7-2 Range Contraction -4.80%
Inside Day Range Contraction -4.80%
Older End-of-Day Signals for MYOV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Fertility Reproduction Infertility Related Disorders Endometriosis Fibroids Advanced Prostate Cancer Gnrh Antagonists Male Infertility Pyrimidines Roivant Sciences Uterine Fibroid Uterine Fibroids Gonadotropin Releasing Hormone Antagonist

Is MYOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.9
52 Week Low 13.42
Average Volume 735,877
200-Day Moving Average 20.91
50-Day Moving Average 20.84
20-Day Moving Average 23.22
10-Day Moving Average 23.81
Average True Range 1.11
ADX 31.04
+DI 22.23
-DI 16.45
Chandelier Exit (Long, 3 ATRs) 21.56
Chandelier Exit (Short, 3 ATRs) 22.86
Upper Bollinger Bands 25.01
Lower Bollinger Band 21.43
Percent B (%b) 0.33
BandWidth 15.40
MACD Line 0.74
MACD Signal Line 0.88
MACD Histogram -0.1456
Fundamentals Value
Market Cap 2.05 Billion
Num Shares 90.6 Million
EPS -3.98
Price-to-Earnings (P/E) Ratio -5.68
Price-to-Sales 64.89
Price-to-Book 70.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.81
Resistance 3 (R3) 25.05 24.56 24.44
Resistance 2 (R2) 24.56 24.00 24.44 24.31
Resistance 1 (R1) 23.58 23.65 23.34 23.34 24.19
Pivot Point 23.09 23.09 22.97 22.97 23.09
Support 1 (S1) 22.11 22.53 21.87 21.87 21.01
Support 2 (S2) 21.62 22.18 21.50 20.89
Support 3 (S3) 20.64 21.62 20.76
Support 4 (S4) 20.40